An Open-Label, Multinational, Multicenter, Phase IIIb Study with Subcutaneous Administration of Trastuzumab in Patients with HER2-Positive Early Breast Cancer to Evaluate Patient Satisfaction
- DOI
- 10.4274/ejbh.galenos.2021.2021-9-9
- Published
- 2022-12-30
- Container
- European Journal of Breast Health
- Publisher
- Galenos Yayinevi
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.4274/ejbh.galenos.2021.2021-9-9,
title = {An Open-Label, Multinational, Multicenter, Phase IIIb Study with Subcutaneous Administration of Trastuzumab in Patients with HER2-Positive Early Breast Cancer to Evaluate Patient Satisfaction},
author = {İrfan Cicin and Mohammed Oukkal and Hassen Mahfouf and Amel Mezlini and Blaha Larbaoui and Slim Ben Ahmed and Hassan Errihani and Khalid Alsaleh and Rhizlane Belbaraka and Perran Fulden Yumuk and Burce Goktas and Mustafa Özgüroğlu},
year = {2022},
journal = {European Journal of Breast Health},
doi = {10.4274/ejbh.galenos.2021.2021-9-9},
url = {https://doi.org/10.4274/ejbh.galenos.2021.2021-9-9}
}RIS
TY - JOUR TI - An Open-Label, Multinational, Multicenter, Phase IIIb Study with Subcutaneous Administration of Trastuzumab in Patients with HER2-Positive Early Breast Cancer to Evaluate Patient Satisfaction AU - İrfan Cicin AU - Mohammed Oukkal AU - Hassen Mahfouf AU - Amel Mezlini AU - Blaha Larbaoui AU - Slim Ben Ahmed AU - Hassan Errihani AU - Khalid Alsaleh AU - Rhizlane Belbaraka AU - Perran Fulden Yumuk AU - Burce Goktas AU - Mustafa Özgüroğlu PY - 2022 JO - European Journal of Breast Health DO - 10.4274/ejbh.galenos.2021.2021-9-9 UR - https://doi.org/10.4274/ejbh.galenos.2021.2021-9-9 ER -
APA
Cicin, İ., Oukkal, M., Mahfouf, H., Mezlini, A., Larbaoui, B., Ahmed, S. B., Errihani, H., Alsaleh, K., Belbaraka, R., Yumuk, P. F., Goktas, B., & Özgüroğlu, M. (2022). An Open-Label, Multinational, Multicenter, Phase IIIb Study with Subcutaneous Administration of Trastuzumab in Patients with HER2-Positive Early Breast Cancer to Evaluate Patient Satisfaction. European Journal of Breast Health. https://doi.org/10.4274/ejbh.galenos.2021.2021-9-9
Source records
- crossref · retrieved 2026-09-26T20:24:46.677Z